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In vitro maintenance of stem cells is crucial for many clinical applications. Stem cell preservation factor FRIL (Flt3 receptor-
interacting lectin) is a plant lectin extracted from Dolichos Lablab and has been found preserve hematopoietic stem cells in
vitro for a month in our previous studies. To investigate whether FRIL can preserve neural progenitor cells (NPCs), it was
supplemented into serum-free suspension culture media. FRIL made NPC grow slowly, induced cell adhesion, and delayed
neurospheresformation.However,FRILdidnotinitiateNPCdiﬀerentiationaccordingtoimmunoﬂuorescenceandsemiquantitive
RT-PCR results. In conclusion, FRIL could also preserve neural progenitor cells in vitro by inhibiting both cell proliferation and
diﬀerentiation.
Copyright © 2008 Hailei Yao et al. This is an open access article distributed under the Creative Commons Attribution License,
which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
1. INTRODUCTION
Stemcellsareuniquecellsthatretaintheability todivide and
proliferate throughout postnatal life to provide progenitor
cells that can progressively become committed to produce
specialized cells. Many cytokines have been reported as
i n d u c e r so fs t e mc e l lp r o l i f e r a t i o na n dd i ﬀerentiation, one
of them is FL (Flt3 ligand) which can prolong maintenance
of primitive human cord blood cells in stromal-free sus-
pension cultures [1–4]. However, FL-containing cultures still
cause the loss of repopulating capacity of primitive cells
[5–10].
We have extracted and identiﬁed a new legume lectin
from Hyactinth bean [11]. It is a ligand of receptor tyrosine
kinase Flt3 which is strictly expressed in hematopoietic
and neural cell lines [12–14] .G a b r i e l l ah a sr e p o r t e dan e w
ﬂt3 ligand which has the ability to preserve hematopoietic
progenitor cells in vitro for 4 weeks [15]. The gene and
protein sequences of our protein are quite similar to
Gabriella’s protein [11], besides our protein is also capable of
long time in vitro preservation of hematopoietic progenitor
cells. According to previous reports [15–19], we named
our protein FRIL too and found that FRIL could maintain
hematopoietic stem cell in G0/G1 phase for at least 4 weeks.
Low activation of FRIL’s receptor Flt3 is considered the
key mechanism through which FRIL preserves cells. Further
experiments showed that FRIL inhibited hematopoietic
stem/progenitor cell (HSPC) apoptosis by upregulating p53,
reduced activation of MAPK and phosphorylation of STAT5,
disturbed formation of AP-1 complex, and in the end
suppressed the expression/activation of cell cycle proteins
[20–22].
Over the last decade, neural stem cell research pro-
vided penetrating insights into plasticity and regenerative
medicine.Stemcellshavebeenisolatedfrombothembryonic
and adult nervous system [23, 24]. Although with the help
of extrinsic signaling factors progress has been made in
understanding fundamental stem cell properties, processes
that determine cell fate or that maintain a cell’s primitive
state are still unknown. As a following experiment to ﬁnd
out whether FRIL can preserve neural progenitor cells as
it does on HSPCs, we ﬁrst identiﬁed the isolated neural
progenitor cells (NPCs) and their ﬂt3 expressing levels, then
we supplemented FRIL into diﬀerent NPC suspension cul-
ture media, observed cell morphological changes, analyzed
cell growth and cell surface marker expression, ﬁnally we
used semiquantitive RT-PCR to verify the changes in gene
expression.2 Clinical and Developmental Immunology
2. MATERIALS AND METHODS
2.1. NPCsisolationandcellculture
E13.5 SD rats (experimental animals department, Peking
University, Beijing, China) were sacriﬁced, then fetal embry-
onic telencephalon and mesencephalon were dissected under
the dissecting microscope, after digestion in the steril-
ized tube, cells were seeded in 25cm2 ﬂask for general
culture and passage. Meanwhile statistically supplemented
EGF(20ng/mL), bFGF(20ng/mL), and FRIL(300μg/mL,
1:1000) into basic culture media(98% DMEM/F12 (1:1)
and2%B27/N2)toformeightgroupsofculturemedia(con-
trol,EGF,bFGF,FRIL,EGF&bFGF,EGF&FRIL,bFGF&FRIL,
EGF&bFGF&FRIL). After second passage, equal numbers
of NPCs were seeded with these diﬀerent culture media.
Furthermore, some NPCs were seeded in diﬀerentiation
media which contains 5% fetal bovine serum. Culture
media comprised a low percent of glucose and did not
containmannosewhichmayexertednegativeeﬀectonFRIL’s
function [15].
2.2. IdentiﬁcationofNPCsand
expressionofﬂt3onNPCs
P2 neurospheres were transferred into poly-l-lysine (pll)
precoated 24-well plate, incubated for 8 hours at 37◦C,
and then stained by nestin for immunoﬂuorescence for the
purpose of NPCs identiﬁcation. Meanwhile, some other
neurospheres were treated with HRP conjugated FRIL in
order to ﬁnd out the proportion of ﬂt3 expressed on NPCs.
2.3. Cellcountingassay
Cells were harvested at day 7 following seeding, resuspended
with PBS after digestion and centrifuge, and then seeded on
96-well plate together with 100μL solution and 10μL CCK-
8(Cat. no. CK04, Dojindo Laboratories Co, Japan.) per well.
Platewasincubatedat37◦C,for4hours,thentheabsorbance
at 450nm was measured using microplate reader with a
reference wavelength at 650nm(Bio-Rad Model 550). Data
was analyzed by SAS 8.2 software.
2.4. Morphologicalobservation
P3 NPCs were harvested and digested into single cell, cells
were counted and seeded into 25cm2 ﬂ a s k sw i t had e s i t yo f
5 × 104 per mL. Each ﬂask was supplemented with only one
media described above, and NPC morphology was observed
everyday.
2.5. Immunoﬂuorescenceassay
NPCs were seeded into pll precoated 24-well plate and incu-
bated at 37◦Cf o r8h o u r s ,ﬁ x e dw i t h4 %p a r a f o r m a l d e h y d e
for 20 minutes, washed with PBS 5 minutes three times,
0.3% Triton X-100 20 minutes, PBS 5 minutes three times,
then were incubated with primary antibody for 2 hours
at 37◦C, washed, and incubated with secondary antibody
for 30 minutes at 37◦C. Primary antibodies that were used
include nestin (Mouse Anti-Nestin Monoclonal Antibody,
Cat. no. MAB353, Chemicon, Inc, USA.), GFAP (Cat. no.
ZA-0117, Beijing Zhongshan Golden Bridge Biotechnology
Co., Ltd.), NSE (RABBIT ANTI-NSE, Cat. no. BA0535,
Boster Biotechnology Co. Ltd.), Tubulin (Monoclonal Anti-
β-Tubulin III antibody produced in mouse Clone SDL.3D10,
ascites ﬂuid, Cat. no. T 8660, Sigma-Aldrich Co, USA.), O4
(Mouse Anti-Oligodendrocyte Marker O4 Monoclonal Anti-
body, Cat. no. MAB345, Chemicon, Inc. USA.). All primary
antibodies were diluted with PBS and 10% normal goat
serum. Secondary antibodies included FITC (Fluorescein-
Conjugated) AﬃniPure Goat Anti-Mouse IgG (H+L) (Cat.
no. ZF-0312, Beijing Zhongshan Golden Bridge Biotechnol-
ogy Co., Ltd.), Rhodamine (TRITC)-Conjugated AﬃniPure
Goat Anti-Mouse IgG (H+L) (Cat. no. ZF-0313, Beijing
Zhongshan Golden Bridge Biotechnology Co., Ltd.), Rho-
damine (TRITC)-conjugated Aﬃnipure Goat Anti-Rabbit
IgG (H+L) (Cat. no. ZF-0316, Beijing Zhongshan Golden
Bridge Biotechnology Co., Ltd.). When cells were stained
for nestin together with GFAP, Tubulin or NSE, primary
and secondary antibodies for each were added simul-
taneously. 4 ,6 -Diamidino-2-phenylindole dihydrochloride
(DAPI; 1:10000) was used in all ﬂuorescence facilitating cell
c o u n t s .I m a g e sf o rc e l lc o u n t sw e r ec a p t u r e df r o ms i xe q u a l l y
spaced, predetermined areas of each well under ﬂuorescence
microscope. NPCs, neurons, glials, and other cells on the
images were counted and analyzed.
2.6. SemiquantitiveRT-PCRassay
mRNA was isolated using trizol kit according to manufac-
ture protocols, then mRNA was reverse transcripted in a ﬁ-
nal volume of 100μL, 42◦C5m i n u t e s ,4 2 ◦C 1 hour, 94◦C
5m i n u t e s ,−20◦C. Then, ACTIN F5  TACCACTGGCATCG
RGATGGACT 3  R5  TCCTTCTGCATCCTGTCGGCAAT
3  94◦C 30 seconds, 59◦C 30 seconds, 72◦C 30 seconds,
25 cycles, 72◦C 5 minutes, 4◦C. GFAP F5  GAAGAAAA
CCGCATCACCAT3  R5  GCACACCTCACATCACATCC3 
94◦C 30 seconds, 57◦C 30 seconds, 72◦C 30 seconds, 25
cycles, 72◦C 5 minutes, 4◦C. Nestin F5  GGAGCCATTGTG
GTCTACTGA3  R5  TCCCACCGCTGTTGATTT3  94◦C
30sec, 56◦C 30 seconds, 72◦C3 0s e c o n d s ,2 8c y c l e s ,7 2 ◦C5
minutes, 4◦C. NeuroD1 F5  ACCTGCTGCCCAGAGTTTTA
3  R5  CAGAGGCTACCGAGGACTTG3  94◦C 30 seconds,
59◦C 30 seconds, 72◦C3 0s e c o n d s ,3 5c y c l e s ,7 2 ◦C 5 min-
utes, 4◦C. NeuroD2 F5  GGGACTCGCCTTCTCTCTCT3 R
5 CTATCCCCGAAACTCAGCAG3  94◦C 30 seconds, 59◦C
30 seconds, 72◦C3 0s e c o n d s ,4 0c y c l e s ,7 2 ◦C 5 min-
utes, 4◦C. NeuroD3 F5  CAGTAGTCCCTCGGCTTCAG3 R
5 TAGACTGGGGCAGGAAAGAA3  94◦C 30 seconds, 59◦C
30 seconds, 72◦C3 0s e c o n d s ,4 0c y c l e s ,7 2 ◦C 5 min-
utes, 4◦C. Ngn3 F5  AGGGGACACACGATTAGCAG3 R
5 GGTCTCTTGGGACACTTGGA3  94◦C 30 seconds, 59◦C
30 seconds, 72◦C3 0s e c o n d s ,3 8c y c l e s ,7 2 ◦C 5 min-
utes, 4◦C. Notch F5  GGTGGACATTGACGAGTGTG3  R
5 CCCTTGAGGCATAAGCAGAG3  94◦C 30 seconds, 59◦C
30 seconds, 72◦C 30 seconds, 27 cycles, 72◦C 5 minutes, 4◦C.
20μL of each samples of PCRs were run on 10% TAE PAGE
stained with ethidium bromide. Gel image were saved asHailei Yao et al. 3
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Figure 1: Neural progenitor cell identiﬁcation and Flt3 expression. (a) Neurospheres under bright ﬁeld. (b) Flt3-HRP staining on neural
spheres. (c) nestin immunoﬂuorescence on neurospheres, RED nestin, BLUE DAPI. (d) Nestin immunoﬂuorescence on single NPC, GREEN
nestin, BLUE DAPI.
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Figure 2: Cell counting assay. Cells were cultured in eight media
with diﬀerent growth factors combination represented in ﬁgure by
control, FRIL, bFGF, bFGF&FRIL, EGF, EGF&FRIL, bFGF&EGF,
bFGF&EGF&FRIL. Cell numbers were transferred into absorption
value obtained from microplate reader Bio-Rad Model 550.
TIFF ﬁles using AlphaImager3300 (Serial no. 981878, Alpha
Inc, China.). Gel band quantitation analysis was performed
via analysis tools of AlphaImager3300.
3. RESULTS
3.1. NPCsidentiﬁcation,ﬂt3expression,andneural
progenitorcellgrowthassay
Primer (P0) cells began to form regular spheres on day 2
after dissection (Figure 1(a)), although some cell death was
evident by the presence of cell fragments. More than 98%
of the P2 cells were nestin-positive, indicating they were
NPCs (Figures 1(c), 1(d)). While more than 95% of cells
werepositiveforFRIL-HRPstain,indicatingthatmostNPCs
expressed ﬂt3 protein (Figure 1(b)).
Then it came to the NPCs in vitro growth assay. FRIL
can promote NPCs growth (P<. 0001). However, FRIL is
less eﬀective than bFGF (P<. 0001) and EGF (P<. 0001)
(Figure 2).
3.2. FRILdelayedformationofneurospheresand
inducedcelladhesion
Whenseeded,NPCsformedsphereslaterinmediawithFRIL
than those without FRIL. Although there were neurospheres
in FRIL containing media, these spheres were smaller than
those formed in media without FRIL (Figures 3(b), 3(d),
3(f), 3(h)). Especially in FRIL medium, there were many
single/two cells and some small neurospheres which mostly
had 3 or 4 cells (Figure 3(b)).
After P3 NPCs were seeded, there was no diﬀerence
on cell growth in media with/without FRIL from day 1
to day 4 after seeding. However, after day 4, cells in FRIL
containingmediaadheredtotheﬂasksurface(Figure 3).And
thisphenomenontookplaceagainwhenNPCswerecultured
after passage.
NPCs cultured in diﬀerentiation media showed diﬀer-
ence from day 3 to day 7 after seeding. Cells in serum
media seemed to begin to grow on day 3 and covered the
bottom of well/ﬂask on day 6/day 7, while cells in FRIL
and serum containing media still spoted on the bottom or
just formed some colonies. However, from day 7 on cells in
FRIL and serum-containing media reached conﬂuency. Most
cells showed glial-like morphology. 1∼3 neuron-like cells per
well existed in serum-containing media, while 13∼21 cells
were present in FRIL and serum-containing media (data not
shown).
3.3. FRILreducedGFAPexpressionwhile
maintainedNSEexpression
We immunostained cells, nestin for NPCs, GFAP for astro-
cytes, NSE/tubulin for neurons, and O4 for oligodendro-
cytes. Fewer FRIL treated NPCs diﬀerentiated into astrocytes
than those not treated by FRIL, despite the fact that they had
adhered to the plates (Figure 4). Oligodendrocytes were not
found. NSE positive cells were not found in culture media
containing EGF and EGF&FRIL too. The number of NSE
positive cells in FRIL containing media was slightly higher
than that without FRIL, although NSE positive rates were4 Clinical and Developmental Immunology
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Figure 3: morphological observation of NPCs cultured in diﬀerent media. (a) NPCs in control medium. (b) NPCs in FRIL medium. (c)
NPCs in bFGF medium. (d) NPCs in bFGF& FRIL medium. (e) NPCs in EGF medium. (f) NPCs in EGF&FRIL medium. (g) NPCs in bFGF
&EGF medium. (h) NPCs in bFGF&EGF&FRIL medium.
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Figure 4: GFAP and nestin immunoﬂuorescence on NPCs cultured in diﬀerent media. (a) NPCs in control medium. (b) NPCs in FRIL
medium. (c) NPCs in bFGF medium. (d) NPCs in bFGF&FRIL medium. (e) NPCs in EGF medium. (f) NPCs in EGF&FRIL medium. (g)
NPCs in bFGF&EGF medium. (h) NPCs in bFGF&EGF&FRIL medium. GREEN nestin, RED GFAP, BLUE DAPI.Hailei Yao et al. 5
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Figure 5: semiquantitive RT-PCR of diﬀerent genes in NPCs
cultured in diﬀerent media. Lane: (C) NPCs in control medium.
(F) NPCs in FRIL medium. (b) NPCs in bFGF medium. (E) NPCs
in EGF medium. (bF) NPCs in bFGF&FRIL medium. (bE) NPCs
in bFGF&EGF medium. (EF) NPCs in EGF&FRIL medium. (bEF)
NPCs in bFGF&EGF&FRIL medium. (S) NPCs in serum medium.
(FS) NPCs in serum&FRIL medium. Row: ngn3, neurogenin3.
NOTCH, notch. NeuroD3, NeuroD3. NeuroD2, NeuroD2. Neu-
roD1, NeuroD1. Nestin, nestin. GFAP, GFAP. ACTIN, actin.
small. In addition, tubulin positive cells were not found in
any media.
3.4. SemiquantitiveRT-PCRanalysisafﬁrmedFRIL
inhibitioninglialdifferentiation
On the basis of previous ﬁndings [25–27], we chosed 5
genes, namely, GFAP and Notch (an indicator of GFAP),
NeuroD1, NeuroD2, NeuroD3,a n dNgn3 (which serves as
upstream regulator of NeuroD) to examine gene expression
of cells in eight diﬀerent cell culture media. GFAP and
nestin were expressed in each group, nestin expression was
similar, while GFAP expression in FRIL containing groups
was lower than those without FRIL (Figure 5). Notch was
not found in control and serum-treated groups, and its
expression was quite opposite to that of GFAP.N e u r o n a l
gene expression was weak, there was no NeuroD3 expression,
NeuroD2 was only expressed in 3 media, although expression
in NeuroD3 and Ngn3 was much higher in FRIL and serum
media than in serum media. Although FRIL might has no
function on neuronal diﬀerentiation, these RT-PCR results
suggested that FRIL inhibited neural progenitor cells from
autodiﬀerentiating into glials.
4. DISCUSSION
98.6% nestin positive cells showed that to some extent all
cells at P2 were NPCs. 95.7% ﬂt3 expression conﬁrmed
the similarities between NPCs and HSCs, although this
contradicted to Brazel’s ﬁndings in which ﬂt3 was expressed
only in NPCs in dorsal root ganglions [12]. The similarities
between NPCs and HSCs [28, 29], especially ﬂt3 expression,
gave us hints on FRIL-NPCs study.
Previous studies showed that the plant lectin FRIL
was successfully extracted from Dolichos lablab using a
mannose aﬃnity column [11, 15]. Although mannose or α-
methyl α-D-mannoside were reported exerting a negative
eﬀects, FRIL had the ability of preserving HSCs in vitro
for a long time [21, 22]. In this study, we reported that
FRIL could also preserve neural progenitor cells as it does
on hematopoietic stem/progenitor cells, it slowed NPC
aggregation and growth, on the other hand it inhibited
NPC glial autodiﬀerentiation, although it might not aﬀect
NPC neuronal autodiﬀerentiation. At present, the common
widely studied neural diﬀerentiation pathways are Notch,
Shh, and so forth [29, 30]. Based on these pathways, both
neuronal and glial RT-PCR results are in coincident with
the results of immunoﬂuorescence. No matter what kinds of
development in which FRIL is involved, the mechanism is
still unclear and further researches in signal pathways should
be done. Depending on our previous studies that FRIL can
aﬀect activities of MAPK, STAT5, and p53, FRIL neural
mechanical researches that may be more complicated could
be performed.
There have been reports that stem cells can be induced
diﬀerentiating into neural cells, however cytokines that
eﬀectively control these cells are still inadequate. FRIL’s
ability to functionally preserve hematopoietic and neural
cells may signiﬁcantly extend the range and time for manip-
ulating these cells. Experiments are underway to ﬁnd out
whether FRIL can improve applications in neural stem cell
transplantation, treatment of neural degenerative diseases,
and cell therapy, and FRIL’s properties of fuctionally select,
preserve, and synchronize hematopoietic cell population
could also give some hints.
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